Equillium (EQ) EBIT Growth (1y) (2019 - 2026)
Equillium (EQ) EBIT Growth (1y) (2019 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
EBIT Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
100.00% |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
12.69% |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
75.16% |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
1.27% |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
-347.04% |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
-230.00% |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
80.62% |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
Equillium |
293.17 Mn |
232.78 Mn |
- |
36.75% |
| Date | Value |
|---|
| Mar 31, 2026 |
36.75% |
| Dec 31, 2025 |
666.41% |
| Sep 30, 2025 |
-573.78% |
| Jun 30, 2025 |
-6,128.00% |
| Mar 31, 2025 |
-217.81% |
| Dec 31, 2024 |
161.03% |
| Sep 30, 2024 |
81.26% |
| Jun 30, 2024 |
97.22% |
| Mar 31, 2024 |
32.06% |
| Dec 31, 2023 |
-256.71% |
| Sep 30, 2023 |
72.63% |
| Jun 30, 2023 |
73.50% |
| Mar 31, 2023 |
89.00% |
| Dec 31, 2022 |
119.66% |
| Sep 30, 2022 |
-34.24% |
| Jun 30, 2022 |
-53.25% |
| Mar 31, 2022 |
-329.32% |
| Dec 31, 2021 |
-15.80% |
| Sep 30, 2021 |
-51.34% |
| Jun 30, 2021 |
-33.78% |
